这是一篇来自已证抗体库的有关人类 FCGR2B的综述,是根据23篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合FCGR2B 抗体。
FCGR2B 同义词: CD32; CD32B; FCG2; FCGR2; FCGR2C; FcRII-c; IGFR2

赛默飞世尔
小鼠 单克隆(6C4 (CD32))
  • 流式细胞仪; 人类; 图 3c
赛默飞世尔 FCGR2B抗体(eBioscience, 6C4)被用于被用于流式细胞仪在人类样本上 (图 3c). Antioxidants (Basel) (2020) ncbi
小鼠 单克隆(6C4 (CD32))
  • 流式细胞仪; 人类; 图 s1g
赛默飞世尔 FCGR2B抗体(eBiosciences, 11-0329-42)被用于被用于流式细胞仪在人类样本上 (图 s1g). Cell Rep (2019) ncbi
小鼠 单克隆(6C4 (CD32))
  • mass cytometry; 人类; 图 s4b
赛默飞世尔 FCGR2B抗体(eBioscience, 6C4)被用于被用于mass cytometry在人类样本上 (图 s4b). Science (2019) ncbi
小鼠 单克隆(6C4 (CD32))
  • 流式细胞仪; 人类; 图 s1b
赛默飞世尔 FCGR2B抗体(eBioscience, 6C4)被用于被用于流式细胞仪在人类样本上 (图 s1b). Cell Host Microbe (2019) ncbi
小鼠 单克隆(6C4 (CD32))
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 FCGR2B抗体(eBioscience, 17-0329-42)被用于被用于流式细胞仪在人类样本上 (图 1a). Mediators Inflamm (2017) ncbi
小鼠 单克隆(6C4 (CD32))
  • 流式细胞仪; 人类; 图 6a
赛默飞世尔 FCGR2B抗体(eBioscience, 17-0329)被用于被用于流式细胞仪在人类样本上 (图 6a). J Neurovirol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5b
赛默飞世尔 FCGR2B抗体(Pierce, PA5-27138)被用于被用于免疫印迹在人类样本上 (图 5b). Oncogene (2017) ncbi
小鼠 单克隆(AT10)
  • 流式细胞仪; 人类; 表 4
赛默飞世尔 FCGR2B抗体(Invitrogen, AT10)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(AT10)
  • 免疫组化-冰冻切片; 小鼠; 1:200; 图 5a
伯乐(Bio-Rad)公司 FCGR2B抗体(Bio-Rad, MCA1075)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200 (图 5a). J Neuroinflammation (2020) ncbi
小鼠 单克隆(AT10)
  • 流式细胞仪; 人类; 图 5b
伯乐(Bio-Rad)公司 FCGR2B抗体(AbD Serotec, AT 10)被用于被用于流式细胞仪在人类样本上 (图 5b). Front Immunol (2018) ncbi
小鼠 单克隆(AT10)
  • 流式细胞仪; 人类; 表 2
伯乐(Bio-Rad)公司 FCGR2B抗体(AbD Serotec, MCA1075PE)被用于被用于流式细胞仪在人类样本上 (表 2). Vet Parasitol (2016) ncbi
小鼠 单克隆(AT10)
  • 流式细胞仪; 人类; 图 1a
伯乐(Bio-Rad)公司 FCGR2B抗体(AbD Serotec, AT10)被用于被用于流式细胞仪在人类样本上 (图 1a). Haematologica (2016) ncbi
小鼠 单克隆(AT10)
  • 流式细胞仪; 仓鼠
伯乐(Bio-Rad)公司 FCGR2B抗体(AbD Serotec, AT10)被用于被用于流式细胞仪在仓鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(AT10)
  • 免疫组化-冰冻切片; 人类; 1:2000
  • 流式细胞仪; 人类; 1:500
伯乐(Bio-Rad)公司 FCGR2B抗体(Serotec, MCA1075)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:2000 和 被用于流式细胞仪在人类样本上浓度为1:500. J Neuroinflammation (2013) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(AT10)
  • 抑制或激活实验; 人类; 图 3a
艾博抗(上海)贸易有限公司 FCGR2B抗体(Abcam, AT10)被用于被用于抑制或激活实验在人类样本上 (图 3a). Sci Rep (2016) ncbi
domestic rabbit 单克隆(EP888Y)
  • 免疫组化-石蜡切片; 猕猴; 1:100
艾博抗(上海)贸易有限公司 FCGR2B抗体(Abcam, Ab45143)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:100. J Immunol (2014) ncbi
domestic rabbit 单克隆(EP888Y)
  • 免疫组化-石蜡切片; 人类; 1:200
艾博抗(上海)贸易有限公司 FCGR2B抗体(Abcam, EP888Y)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Mod Pathol (2014) ncbi
小鼠 单克隆(AT10)
  • 免疫沉淀; 人类
艾博抗(上海)贸易有限公司 FCGR2B抗体(Abcam, ab41899)被用于被用于免疫沉淀在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(AT10)
  • 流式细胞仪; 人类; 图 2
艾博抗(上海)贸易有限公司 FCGR2B抗体(Abcam, clone AT10)被用于被用于流式细胞仪在人类样本上 (图 2). Leuk Lymphoma (2012) ncbi
圣克鲁斯生物技术
小鼠 单克隆(AT10)
  • 酶联免疫吸附测定; 人类; 图 7d
圣克鲁斯生物技术 FCGR2B抗体(Santa Cruz, sc-13527)被用于被用于酶联免疫吸附测定在人类样本上 (图 7d). J Cell Mol Med (2017) ncbi
小鼠 单克隆(AT10)
  • 抑制或激活实验; 小鼠; 图 s1
圣克鲁斯生物技术 FCGR2B抗体(Santa Cruz, sc-13527)被用于被用于抑制或激活实验在小鼠样本上 (图 s1). Med Microbiol Immunol (2016) ncbi
小鼠 单克隆
  • 流式细胞仪; 人类; 图 6a
  • 免疫沉淀; 人类; 图 6b
圣克鲁斯生物技术 FCGR2B抗体(Santa Cruz, AT-10)被用于被用于流式细胞仪在人类样本上 (图 6a) 和 被用于免疫沉淀在人类样本上 (图 6b). J Clin Invest (2014) ncbi
小鼠 单克隆(AT10)
  • 流式细胞仪; 人类; 图 6a
  • 免疫沉淀; 人类; 图 6b
圣克鲁斯生物技术 FCGR2B抗体(Santa Cruz, AT-10)被用于被用于流式细胞仪在人类样本上 (图 6a) 和 被用于免疫沉淀在人类样本上 (图 6b). J Clin Invest (2014) ncbi
BioLegend
小鼠 单克隆(4F5/CD32)
  • 流式细胞仪; 人类; 1:100; 图 6b
BioLegend FCGR2B抗体(Biolegend, 398402)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 6b). Nat Nanotechnol (2022) ncbi
文章列表
  1. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed 出版商
  2. Pu A, Mishra M, Dong Y, Ghorbanigazar S, Stephenson E, Rawji K, et al. The glycosyltransferase EXTL2 promotes proteoglycan deposition and injurious neuroinflammation following demyelination. J Neuroinflammation. 2020;17:220 pubmed 出版商
  3. Bekeschus S, Ressel V, Freund E, Gelbrich N, Mustea A, Stope M. Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity. Antioxidants (Basel). 2020;9: pubmed 出版商
  4. Vijayaraj P, Minasyan A, Durra A, Karumbayaram S, Mehrabi M, Aros C, et al. Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule. Cell Rep. 2019;29:3488-3505.e9 pubmed 出版商
  5. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed 出版商
  6. Bottermann M, Foss S, Caddy S, Clift D, van Tienen L, Vaysburd M, et al. Complement C4 Prevents Viral Infection through Capsid Inactivation. Cell Host Microbe. 2019;25:617-629.e7 pubmed 出版商
  7. Jimenez R, Wright T, Jones N, Wu J, Gibson A, Szalai A. C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. Front Immunol. 2018;9:372 pubmed 出版商
  8. Choi B, Suh C, Kim H, Sayeed H, Sohn S. The Correlation of CD206, CD209, and Disease Severity in Behçet's Disease with Arthritis. Mediators Inflamm. 2017;2017:7539529 pubmed 出版商
  9. Su J, Zhou H, Liu X, Nilsson J, Fredrikson G, Zhao M. oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+ /K+ channel flow. J Cell Mol Med. 2017;21:929-940 pubmed 出版商
  10. Garcia Mesa Y, Jay T, Checkley M, Luttge B, Dobrowolski C, Valadkhan S, et al. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system. J Neurovirol. 2017;23:47-66 pubmed 出版商
  11. Burgess M, Mapp S, Mazzieri R, Cheung C, Chambers L, Mattarollo S, et al. Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients. Oncogene. 2017;36:2366-2376 pubmed 出版商
  12. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed 出版商
  13. Corrales Aguilar E, Trilling M, Reinhard H, Falcone V, Zimmermann A, Adams O, et al. Highly individual patterns of virus-immune IgG effector responses in humans. Med Microbiol Immunol. 2016;205:409-24 pubmed 出版商
  14. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed 出版商
  15. Gazendam R, van de Geer A, van Hamme J, Tool A, van Rees D, Aarts C, et al. Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components. Haematologica. 2016;101:587-96 pubmed 出版商
  16. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  17. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed 出版商
  18. Smith A, Wietgrefe S, Shang L, Reilly C, Southern P, Perkey K, et al. Live simian immunodeficiency virus vaccine correlate of protection: immune complex-inhibitory Fc receptor interactions that reduce target cell availability. J Immunol. 2014;193:3126-33 pubmed 出版商
  19. Ben Mkaddem S, Hayem G, Jönsson F, Rossato E, Boedec E, Boussetta T, et al. Shifting Fc?RIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. J Clin Invest. 2014;124:3945-59 pubmed 出版商
  20. Espinosa I, Catasus L, D Angelo E, Mozos A, Pedrola N, Bertolo C, et al. Stromal signatures in endometrioid endometrial carcinomas. Mod Pathol. 2014;27:631-9 pubmed 出版商
  21. Municio C, Alvarez Y, Montero O, Hugo E, Rodriguez M, Domingo E, et al. The response of human macrophages to ?-glucans depends on the inflammatory milieu. PLoS ONE. 2013;8:e62016 pubmed 出版商
  22. Vogel D, Vereyken E, Glim J, Heijnen P, Moeton M, van der Valk P, et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation. 2013;10:35 pubmed 出版商
  23. Nguyen T, Havari E, McLaren R, Zhang M, Jiang Y, Madden S, et al. Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes. Leuk Lymphoma. 2012;53:699-709 pubmed 出版商